Google
 

Archive for the ‘GastroIntestinal / Gastroenterology’ Category

New NICE Guidelines Mean IBS Sufferers Will Be Tested For Coeliac Disease, UK

Thursday, May 15th, 2008

The symptoms of IBS and coeliac disease can often be very similar as a result the diagnosis of coeliac disease can be delayed or missed and IBS is misdiagnosed. The new guidelines regarding the diagnosis of Irritable Bowel Syndrome (IBS) announced recently by the National Institute for Health and Clinical ...

454 Sequencing For The Characterization Of The Protective Intestinal Flora

Thursday, May 15th, 2008

The diversity of species in the intestinal flora is imperative for the maintenance of our health. Any instability can lead to the development of various intestinal diseases such as antibiotic-associated intestinal inflammations like e.g., Morbus Crohn or Colitis Ulcerosa. According to the latest discoveries, disturbances in the metabolism such as ...

Nitrates In Vegetables Protect Against Gastric Ulcers

Thursday, May 15th, 2008

Fruits and vegetables that are rich in nitrates protect the stomach from damage. This takes place through conversion of nitrates into nitrites by the bacteria in the oral cavity and subsequent transformation into biologically active nitric oxide in the stomach. The Swedish researcher Joel Petersson has described the process, which ...

Since 2004 Foodborne Illness Incidence In America Has Not Dropped, CDC

Saturday, April 12th, 2008

The number of cases of people with reported foodborne illnesses in the United States was dropping until 2004 - since then the numbers have not fallen, according to a report published by the CDC (Centers for Disease Control and Prevention). The new data comes from FoodNet. FoodNet ...

Recombinant Human Intestinal Trefoil Factor (rhITF) Oral Spray For Prophylaxis Of Chemotherapy-induced Oral Mucositis

Tuesday, April 8th, 2008

The GI Company, Inc., a privately held developer of gastrointestinal therapeutics, announced that an abstract detailing combined results from its Phase I and Phase II clinical trials has been accepted for a poster presentation at the Multinational Association of Supportive Care in Cancer's and the International Society of Oral ...

FDA Approves ROTARIX(R) Rotavirus Vaccine

Monday, April 7th, 2008

AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced that its partner, GlaxoSmithKline (GSK), has received approval from the U.S. Food and Drug Administration (FDA) for ROTARIX® for the prevention of rotavirus gastroenteritis in infants. With only two doses, ROTARIX will offer protection against the most commonly circulating rotavirus types in the U.S. ...

Rotarix, An Oral Rotavirus Vaccine, Approved By The FDA

Saturday, April 5th, 2008

The FDA (Food and Drug Administration, USA) has approved Rotarix, an oral vaccine for the prevention of rotavirus - an infection in children and infants which causes vomiting and diarrhea (gastroenteritis). The vaccine, which is presented in liquid form, is given in two doses to infants aged 6 and 24 ...

FDA Approves New Vaccine To Prevent Gastroenteritis Caused By Rotavirus

Friday, April 4th, 2008

The U.S. Food and Drug Administration announced the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children. Rotarix is a liquid and given in a two-dose series to infants from 6 to 24 ...

SAGES/ACS Fundamentals Of Laparoscopic Surgery (FLS) Program Receives Landmark Grant From Covidien

Friday, April 4th, 2008

The Fundamentals of Laparoscopic Surgery (FLS), a joint educational program from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the American College of Surgeons (ACS), has received a $1.8 million grant from Covidien, a leading manufacturer of medical devices and supplies, to launch The Covidien Educational Fund. Covidien ...

AGI Therapeutics Plc Announces Key Findings Of Clinical PK Study Of Arbaclofen (AGI-006)

Thursday, April 3rd, 2008

AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality pharmaceutical company focused on gastrointestinal drug products, announces the key findings of a clinical study to assess the pharmacokinetic profile of arbaclofen (AGI-006), which is being developed for the treatment of gastroparesis, a significant gastric condition amongst diabetics. ...

Burden Of Gastroenteritis On The Island Of Ireland Estimated At Over 135 Million Euros

Wednesday, April 2nd, 2008

1st April 2008: A new safefood study - The Economic Impact of Gastroenteritis on the Island of Ireland has revealed the total burden of gastroenteritis on the economy for the island of Ireland is estimated at over €135 million per annum. ...

Epistem To Provide Preclinical Efficacy Testing Services For Exponential Biotherapies

Tuesday, April 1st, 2008

Epistem (LSE: EHP) announced that Exponential Biotherapies, Inc. (EBI) of Virginia, USA, have contracted Epistem to provide their specialised preclinical efficacy testing services for agents likely to protect the gastrointestinal tract against radiation damage. The first compound that Epistem will assess is EBI's lead candidate drug, EA-230, which is ...

Orexo Announces Results Confirming The Clinical Profile Of OX17 In Reflux Disease (GERD)

Saturday, March 29th, 2008

New clinical data from a phase II study confirms the competitive profile of Orexo's product OX17 in GERD patients, i.e. fast, effective and sustained inhibition of gastric acid production, a prerequisite for effective symptom relief in the patient. The result demonstrates the clinical potential of OX17 and is an important ...

Discovery Of The Brain’s Calorie-Sensing System

Friday, March 28th, 2008

The brain can sense the calories in food, independent of the taste mechanism, researchers have found in studies with mice. Their finding that the brain's reward system is switched on by this "sixth sense" machinery could have implications for understanding the causes of obesity. For example, the findings suggest why ...

Updated Treatment Guidelines For Barrett’s Esophagus Offer New Recommendations For Challenging Clinical Controversies

Friday, March 28th, 2008

Due to the rise in the incidence of esophageal cancers in the United States, and as a result of significant scientific advances in the area of Barrett's esophagus, physician experts from the American College of Gastroenterology have released updated guidelines for the diagnosis, surveillance and treatment of Barrett's esophagus. ...